Candoo Pharmatech
This Canadian formulation provider uses QbD approaches for oral dosage form development and manufacturing process design, including immediate-release, controlled-release, bilayer, orally disintegrating, and sublingual products.
Corporate information
- Company entity
- Candoo Pharmatech
- Headquarters / principal office
- Mississauga, OntarioSelf-reported location on the company LinkedIn page; regional scope may differ from the legal or global headquarters. ↗
- Founded
- 2018 ↗
- Ownership / capital status
- Group subsidiary / business platformGroup subsidiary (no independent financing found) ↗
- Official corporate reference
- https://www.candoopharmatech.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
This Canadian formulation provider uses QbD approaches for oral dosage form development and manufacturing process design, including immediate-release, controlled-release, bilayer, orally disintegrating, and sublingual products.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.